Chemotherapy plus atezolizumab improves survival in metastatic bladder cancer
Article written by Bruce Sylvester
Article written by Bruce Sylvester
The FDA approved Ilaris (canakinumab) injection for the treatment of Active Still’s disease, including Adult-Onset Still’s Disease (AOSD). Ilaris was previously approved for Systemic Juvenile Idiopathic Arthritis (SJIA)… read more.